Display options
Cite
Sun R, Wang J, Zheng Y, et al. Traditional Chinese medicine baoxin decoction improves cardiac fibrosis of rats with dilated cardiomyopathy. Exp Ther Med. 2017;13(5):1900-1906doi: 10.3892/etm.2017.4223.
Sun, R., Wang, J., Zheng, Y., Li, X., Xie, T., Li, R., Liu, M., Cao, Y., Lu, L., Zhang, Q., & Zhang, P. (2017). Traditional Chinese medicine baoxin decoction improves cardiac fibrosis of rats with dilated cardiomyopathy. Experimental and therapeutic medicine, 13(5), 1900-1906. https://doi.org/10.3892/etm.2017.4223
Sun, Rongrong, et al. "Traditional Chinese medicine baoxin decoction improves cardiac fibrosis of rats with dilated cardiomyopathy." Experimental and therapeutic medicine vol. 13,5 (2017): 1900-1906. doi: https://doi.org/10.3892/etm.2017.4223
Sun R, Wang J, Zheng Y, Li X, Xie T, Li R, Liu M, Cao Y, Lu L, Zhang Q, Zhang P. Traditional Chinese medicine baoxin decoction improves cardiac fibrosis of rats with dilated cardiomyopathy. Exp Ther Med. 2017 May;13(5):1900-1906. doi: 10.3892/etm.2017.4223. Epub 2017 Mar 10. PMID: 28565783; PMCID: PMC5443197.
Copy Download .nbib Format: NLM
Share it on

Exp Ther Med. 2017 May;13(5):1900-1906. doi: 10.3892/etm.2017.4223. Epub 2017 Mar 10.

Traditional Chinese medicine baoxin decoction improves cardiac fibrosis of rats with dilated cardiomyopathy.

Experimental and therapeutic medicine

Rongrong Sun, Jiangbo Wang, Yi Zheng, Xianchi Li, Tiantian Xie, Rui Li, Min Liu, Yong Cao, Lei Lu, Qing Zhang, Peiying Zhang

Affiliations

  1. Clinical Medicine, Nanjing University of Traditional Chinese Medicine, The Affiliated Xuzhou Central Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu 210023, P.R. China.
  2. Department of Neurology, Xuzhou Central Hospital, Xuzhou, Jiangsu 221009, P.R. China.
  3. Department of Cardiology, Xuzhou Central Hospital, Xuzhou, Jiangsu 221009, P.R. China.
  4. Department of Cardiology, Xuzhou Hospital of Traditional Medicine, Xuzhou, Jiangsu 221009, P.R. China.
  5. Department of Cardiology, The Affiliated Xuzhou Central Hospital of Nanjing University of Traditional Chinese Medicine, The Affiliated Xuzhou Hospital of Medical School of Southeast University, Xuzhou, Jiangsu 221009, P.R. China.

PMID: 28565783 PMCID: PMC5443197 DOI: 10.3892/etm.2017.4223

Abstract

We investigated the effect of baoxin decoction (BXD) on myocardial fibrosis and clarified the possible mechanism of action. Dilated myocardiopathy was induced by doxorubicin injected intraperitoneally for 6 weeks. Rats that demonstrated dilated myocardiopathy were randomly divided into five groups plus a control group. Three groups were treated with BXD (7.5/kg, 15 g/kg and 30 g/kg) daily for 4 weeks. One group was treated with 8.75 g/kg of captopril (positive control), and with physiologic saline (negative control). Cardiac function was evaluated using echocardiography. Hematoxylin and eosin, and Massons trichrome staining were performed, PICP and PIIINP were assessed by ELISA, the expression of galectin-3 and collagen types I and III was evaluated with reverse transcription-quantitative PCR, and interrelated proteins were detected by western blot analysis. BXD downregulated galectin-3, collagen I and III and was correlated with a high expression of fibrosis markers. It also significantly decreased myocardial collagen volume fraction (CVF), together with markedly preventing the upregulation of collagen I and III. In addition, BXD downregulated the expression of TGF-β1 and Smad3 in the myocardial fibrosis rats. Therefore, BXD treatment significantly improved cardiac function and alleviated myocardial fibrosis in a rat model of doxorubicin-induced dilated cardiomyopathy (DCM), which is the mechanism that may be associated with inhibiting the TGF-β1 signaling pathway.

Keywords: baoxin decoction; cardiac fibrosis; dilated cardiomyopathy; traditional Chinese medicine

References

  1. Am Heart J. 2013 Jun;165(6):995-9 - PubMed
  2. Evid Based Complement Alternat Med. 2014;2014:323870 - PubMed
  3. JAMA. 2006 Oct 18;296(15):1867-76 - PubMed
  4. PLoS One. 2015 Mar 20;10(3):e0121312 - PubMed
  5. Acta Pharmacol Sin. 2010 Oct;31(10):1350-8 - PubMed
  6. Cardiovasc Ther. 2012 Apr;30(2):117-23 - PubMed
  7. Clin Lab Med. 2014 Mar;34(1):87-97, vi-vii - PubMed
  8. Cardiovasc Res. 1998 Jul;39(1):216-23 - PubMed
  9. J Biol Chem. 1994 Aug 19;269(33):20807-10 - PubMed
  10. Circ Res. 1989 Jun;64(6):1041-50 - PubMed
  11. J Am Assoc Lab Anim Sci. 2007 Jul;46(4):20-32 - PubMed
  12. J Cardiovasc Transl Res. 2013 Aug;6(4):516-27 - PubMed
  13. Cancer Chemother Pharmacol. 2009 Jan;63(2):343-9 - PubMed
  14. Isr Med Assoc J. 2014 Jul;16(7):444-5 - PubMed
  15. Cardiovasc Res. 2010 Aug 1;87(3):504-13 - PubMed
  16. J Ethnopharmacol. 2014 Nov 18;157:161-70 - PubMed
  17. J Thyroid Res. 2013;2013:264387 - PubMed
  18. JACC Heart Fail. 2015 Jan;3(1):50-8 - PubMed
  19. Hypertension. 2010 May;55(5):1088-9 - PubMed
  20. J Pharm Pharmacol. 2013 Sep;65(9):1373-81 - PubMed
  21. Circ Heart Fail. 2013 Jan;6(1):107-17 - PubMed
  22. Chin J Integr Med. 2011 Nov;17(11):818-23 - PubMed
  23. J Clin Pathol. 2009 Mar;62(3):219-25 - PubMed
  24. Cell Mol Life Sci. 2014 Feb;71(4):549-74 - PubMed
  25. J Altern Complement Med. 2012 Apr;18(4):318-28 - PubMed
  26. Circ Res. 2010 Mar 19;106(5):992-1003 - PubMed
  27. Circulation. 2004 Nov 9;110(19):3121-8 - PubMed
  28. Circ Res. 2010 Aug 6;107(3):418-28 - PubMed

Publication Types